Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
ECF regimen
Description:
A chemotherapy combination of epirubicin, cisplatin, and fluorouracil, used to treat cancers including advanced gastric cancer.
Primary topic:
Gastric Cancer Management and Outcomes (72%)
Related topics:
Gastric Cancer Management and Outcomes (72%),
Esophageal Cancer Research and Treatment (8%)
OpenAlex ID:
keywords/ecf-regimen
Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer
2006
·
David Cunningham
, William H. Allum
, et al.
·
New England Journal of Medicine
·
6,818
Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.
1997
·
A Webb
, D Cunningham
, et al.
·
Journal of Clinical Oncology
·
903
Prospective Randomized Trial Comparing Mitomycin, Cisplatin, and Protracted Venous-Infusion Fluorouracil (PVI 5-FU) With Epirubicin, Cisplatin, and PVI 5-FU in Advanced Esophagogastric Cancer
2002
·
P. Ross
, M. Nicolson
, et al.
·
Journal of Clinical Oncology
·
500
Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial
1999
·
J S Waters
, A Norman
, et al.
·
British Journal of Cancer
·
282
PDF
Docetaxel, Cisplatin, and Fluorouracil; Docetaxel and Cisplatin; and Epirubicin, Cisplatin, and Fluorouracil As Systemic Treatment for Advanced Gastric Carcinoma: A Randomized Phase II Trial of the Swiss Group for Clinical Cancer Research
2007
·
Arnaud D. Roth
, Nicola Fazio
, et al.
·
Journal of Clinical Oncology
·
258
TOPGEAR: A Randomized, Phase III Trial of Perioperative ECF Chemotherapy with or Without Preoperative Chemoradiation for Resectable Gastric Cancer: Interim Results from an International, Intergroup Trial of the AGITG, TROG, EORTC and CCTG
2017
·
Trevor Leong
, B. Mark Smithers
, et al.
·
Annals of Surgical Oncology
·
252
High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer.
1995
·
I E Smith
, G Walsh
, et al.
·
Journal of Clinical Oncology
·
185
Palliative chemotherapy for advanced gastric cancer
2004
·
S.S. Wöhrer
, M. Raderer
, et al.
·
Annals of Oncology
·
181
Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF
2005
·
K Sumpter
, C Harper-Wynne
, et al.
·
British Journal of Cancer
·
155
PDF
Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer
2005
·
S Rao
, D Cunningham
, et al.
·
British Journal of Cancer
·
145
PDF
Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance)
2017
·
Charles S. Fuchs
, Donna Niedzwiecki
, et al.
·
Journal of Clinical Oncology
·
143
Epirubicin, cisplatin and infusional 5-fluorouracil (5-FU) (ECF) in hepatobiliary tumours
1995
·
P.A. Ellis
, A. Norman
, et al.
·
European Journal of Cancer
·
136
Perioperative chemotherapy in operable gastric and lower oesophageal cancer: Final results of a randomised, controlled trial (the MAGIC trial, ISRCTN 93793971)
2005
·
D. Cunningham
, W. H. Allum
, et al.
·
Journal of Clinical Oncology
·
128
Docetaxel and Continuous-Infusion Fluorouracil Versus Epirubicin, Cisplatin, and Fluorouracil for Advanced Gastric Adenocarcinoma: A Randomized Phase II Study
2005
·
Peter C. Thuss-Patience
, Albrecht Kretzschmar
, et al.
·
Journal of Clinical Oncology
·
121
PDF
Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC) - gastrointestinal cancer group
2008
·
Eric Van Cutsem
, Cornelius Van de Velde
, et al.
·
European Journal of Cancer
·
104
Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel
2007
·
Rosalba Torrisi
, Alessandra Balduzzi
, et al.
·
Cancer Chemotherapy and Pharmacology
·
96
Phase II/III multicentre randomised controlled trial evaluating a strategy of primary surgery and adjuvant chemotherapy versus peri-operative chemotherapy for resectable gastric signet ring cell adenocarcinomas – PRODIGE 19 – FFCD1103 – ADCI002
2013
·
Guillaume Piessen
, Mathieu Messager
, et al.
·
BMC Cancer
·
82
PDF
Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for esophagogastric adenocarcinoma: Response, toxicity, quality of life, and survival
1996
·
Aris Bamias
, Mark E. Hill
, et al.
·
Cancer
·
82
Phase II study of continuous infusion fluorouracil with epirubicin and cisplatin in patients with metastatic and locally advanced breast cancer: an active new regimen.
1994
·
A L Jones
, I E Smith
, et al.
·
Journal of Clinical Oncology
·
78
Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5‐fluorouracil in patients with unresectable biliary tract tumors
2005
·
Maurizio Cantore
, Andrea Mambrini
, et al.
·
Cancer
·
77
The UK NCRI MAGIC Trial of Perioperative Chemotherapy in Resectable Gastric Cancer: Implications for Clinical Practice
2007
·
Yu Jo Chua
, David Cunningham
·
Annals of Surgical Oncology
·
75
PDF
The Royal Marsden experience of small bowel adenocarcinoma treated with protracted venous infusion 5-fluorouracil
1998
·
C Crawley
, P Ross
, et al.
·
British Journal of Cancer
·
75
PDF
The role of chemotherapy in metastatic gastric cancer.
2011
·
Felice Pasini
, Anna Paola Fraccon
, et al.
·
PubMed
·
72
Treatment of hepatocellular carcinoma (HCC) with systemic chemotherapy combining epirubicin, cisplatinum and infusional 5-fluorouracil (ECF regimen)
2002
·
Eveline Boucher
, Stéphane Corbinais
, et al.
·
Cancer Chemotherapy and Pharmacology
·
72
Docetaxel-based chemotherapy in the treatment of gastric cancer
2003
·
A.D. Roth
, J. Ajani
·
Annals of Oncology
·
68
PDF
Show more works
View as search
Works count:
285
Citation count:
12,850
Year
Topic
Type